HSF Danby Research Grant Program in United States

The HSF Danby Research Grant Program, offered by the Hidradenitis Suppurativa Foundation (HSF), invites proposals for research into hidradenitis suppurativa (HS). The program aims to foster new clinical and translational research initiatives that enhance patient care. Applications must be submitted by 7 December 2026. Opportunity at a Glance

- Provider: Hidradenitis Suppurativa Foundation (HSF)

- Opportunity Type: Research Grant

- Funding Amount: Up to $30,000 per year (direct costs only)

- Eligible Applicants: Investigators in the United States

- Deadline: 7 December 2026

- Project Duration: 1 June 2027 – 31 May 2028

- Notification of Award: March 2027 at the AAD Annual Meeting

About the Opportunity

The HSF Danby Research Grant Program supports research initiatives that seek to advance understanding and treatment of hidradenitis suppurativa. The program encourages innovative research strategies that can lead to significant improvements in patient outcomes. Funding and Benefits

- Maximum Grant Amount: Up to $30,000 per year for direct costs.

- Expenditure Period: All funds must be used within the one-year project period.

- Additional Support: Up to $1,500 per individual is available for travel expenses to present findings at the Symposium on Hidradenitis Suppurativa Advances (SHSA). Who Is Eligible?

- Eligible Applicants: Investigators based in the United States who are personally responsible for conducting the proposed research.

- Priority Given To: Early-stage investigators.

- Exclusions: Projects within the NIH intramural research program and applications from private foundations without an academic dermatology affiliation. Eligible Activities or Priority Areas The program seeks research proposals that are relevant to hidradenitis suppurativa, innovative, and likely to enhance patient care or disease awareness. Clinical trials are discouraged due to funding limitations. Why This Opportunity Matters This grant provides vital funding for research into hidradenitis suppurativa, a chronic skin condition. By supporting innovative projects, the program aims to improve patient care and expand scientific understanding of the disease. How to Apply

- Access the Application Portal: Follow the official link provided by the HSF.

- Prepare Your Application: Ensure it includes all required sections such as a title page, abstract, budget, biographical sketches, and research proposal.

- Document Requirements: Include letters of support and approval for human and animal studies, if applicable.

- Submit by Deadline: Complete your submission by 7 December 2026.

Application Tips or Common Mistakes

- General Advice: Ensure clarity and conciseness in all sections, particularly in the research proposal and budget justification.

- Avoid Common Errors: Double-check that all documents, especially biographical sketches and letters of support, adhere to specified formats and page limits.

Frequently Asked Questions What is the funding limit per grant? Each grant may provide up to $30,000 for direct costs within the project year. Who can apply for this grant? Investigators based in the United States who are responsible for their proposed research can apply. Are clinical trials eligible for this grant? Clinical trials are discouraged due to the limited funding amount. What is the deadline for applications? Applications must be submitted by 7 December 2026. Can travel expenses be covered by the grant? Travel expenses are not covered by the grant, but HSF provides up to $1,500 for grantees to present at the SHSA. Next Steps Eligible applicants should review the official guidelines and submit their applications through the designated portal by the deadline. For further details, consult the HSF website.